PHARMACEUTICALS

China to speed up drug approvals, will accept overseas trial data

China to speed up drug approvals, will accept overseas trial data

Published 09/10/2017

China is looking to speed up approvals for new drugs and plans to accept data from clinical trials carried out overseas, a potential boon for international drugmakers and patients who often face lengthy delays for new medicines to reach the market. [more…]

UK report plans boost for life sciences as Brexit looms

UK report plans boost for life sciences as Brexit looms

Published 30/08/2017

The British government has rekindled its industrial strategy, unveiled earlier this year to prepare the economy for Brexit, with plans to boost the country's pharmaceuticals sector via fresh investments and public-private collaborations. [more…]

Lupin sets off down Indian pharma`s long road to redemption

Lupin sets off down Indian pharma`s long road to redemption

Published 09/07/2017

An employee inspects tablets as they move along the production line at a pharmaceutical plant of Lupin, India's No. 2 drugmaker, in Verna, in the western state of Goa, India, June 9, 2017. Picture taken June 9, 2017. REUTERS/Danish Siddiqui

In 28 years in India's pharmaceuticals sector, Rajiv Desai has never been busier.

[more…]

Generic drug group sues to block Maryland price-gouging law

Generic drug group sues to block Maryland price-gouging law

Published 06/07/2017

The main U.S. trade group for generic pharmaceutical companies filed a lawsuit on Thursday seeking to block a recently adopted Maryland law that lets the state attorney general sue generic drugmakers that sharply raise prices.

[more…]

Big pharma turns to AI to speed drug discovery, GSK signs deal

Big pharma turns to AI to speed drug discovery, GSK signs deal

Published 02/07/2017

FILE PHOTO: Signage for GlaxoSmithKline is seen on its offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo

The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday.

[more…]

Drug approvals bounce back as R&D labs churn out new winners

Drug approvals bounce back as R&D labs churn out new winners

Published 25/05/2017

FILE PHOTO - A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo

The number of new drugs approved for sale in United States and Europe has bounced back this year, suggesting a marked slowdown in 2016 was an aberration rather than a sign of flagging research and development productivity.

[more…]

Deadly brain infection in German MS patient prompts Roche investigation

Deadly brain infection in German MS patient prompts Roche investigation

Published 24/05/2017

The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, January 30, 2014. REUTERS/Ruben Sprich/File Photo

A person in Germany treated with Roche Holding AG’s new multiple sclerosis drug Ocrevus has been diagnosed with an often-deadly brain infection after switching from another medication earlier this year, the Swiss drugmaker said on Wednesday.

[more…]

Drugs firms call for phased transition of regulation after Brexit

Published 26/04/2017

Pharmaceutical companies called on Thursday for a phased transition in drug regulation after Britain leaves the European Union, in order to avoid supply disruption and protect public health.

[more…]

EU drugmakers urge June decision on new location for watchdog

EU drugmakers urge June decision on new location for watchdog

Published 23/04/2017

Guido Rasi, executive director the European Medicines Agency (EMA), poses for a portrait at his office in London, Britain, January 6, 2012. REUTERS/Finbarr O'Reilly/File Photo

Europe's drugmakers pushed for a decision as early as June on the new location for the headquarters of the bloc's medicines watchdog, which will relocate from London after Britain's decision to leave the EU.

[more…]

China considers ways to speed up time to market for imported drugs

China considers ways to speed up time to market for imported drugs

Published 20/03/2017

A man talks on the phone near a sign for the reception office of China's Food and Drug Administration in Beijing, China, May 17, 2016. REUTERS/Damir Sagolj

China is considering taking measures that will shorten the time to market for approved imported drugs in an effort to ease a shortage of such medicines, according to the China Food and Drug Administration (CFDA).

[more…]